Protein kinases A and C regulate amyloid-ß degradation by modulating protein levels of neprilysin and insulin-degrading enzyme in astrocytes.
Neurosci Res
; 166: 62-72, 2021 May.
Article
em En
| MEDLINE
| ID: mdl-32512031
The pathology of sporadic Alzheimer's disease is hallmarked by altered signal transduction via the neurotransmitter receptor-G-protein-mediated protein kinase A (PKA) and protein kinase C (PKC) pathways. Because the accumulation of amyloid-ß (Aß) depends on its rates of synthesis and clearance, the metabolic pathway of Aß in the brain and the entire body warrants exploration. The two major enzymes involved in Aß degradation in the brain are believed to be the neprilysin and insulin-degrading enzyme (IDE). This study investigated whether PKA and PKC regulate the degradation of Aß by modulating the protein levels of neprilysin and IDE in astrocytes. Activation of PKA induced a significant decrease in neprilysin protein levels in cultured astrocytes, whereas activation of PKC induced a significant decrease in the protein level of neprilysin and an increase in the protein level of IDE. Following activation of PKC, the reduction of neprilysin was achieved by its secretion into the culture media. Moreover, PKA-activated astrocytes significantly delayed the degradation of exogenous Aß, whereas PKC-activated astrocytes significantly facilitated its degradation. These results suggest that PKA and PKC regulate Aß degradation in astrocytes through a decrease in the protein level of neprilysin and an increase in neprilysin secretion and protein levels of IDE, respectively.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Proteína Quinase C
/
Neprilisina
/
Astrócitos
/
Peptídeos beta-Amiloides
/
Proteínas Quinases Dependentes de AMP Cíclico
/
Doença de Alzheimer
/
Insulisina
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article